10h
No more guesswork in drug design—atomic-resolution method exposes what trial and error keep missing
Drug discovery still too often relies on expensive trial and error. Researchers from ICTER show there is another way—building ...
Drug companies are more likely to keep research and development (R&D) in-house, rather than outsource it, when they already ...
WuXi AppTec, a leading global contract research, development, and manufacturing organization (CRDMO) presented 13 scientific posters at the 2026 Annual Meeting of the American Association for Cancer ...
Hosted on MSN
AlphaFold opens new doors in drug development—how
AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...
Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science.
The 5th Circuit’s ruling on mifepristone “is bad for health care access, and it’s also bad for innovation,” writes Grace E.
Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer ...
By Michael Erman NEW YORK, April 27 (Reuters) - Johnson & Johnson is using artificial intelligence to slash by half the time ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results